Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy

Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy - Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038328

Enrollment

Registered

2019-10-30

Start date

2019-10-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients underwent GSA SPECT and MRI, among who were / will be treated with carbon ion radiotherapy for liver tumors from December 2018 to September 2020 at QST hospital.

Exclusion criteria

Exclusion criteria: 1.Other cause of death within 12 months after carbon ion radiotherapy. 2.Recurrence cases within 12 months after carbon ion therapy. 3.Patients who were received other anticancer treatments within 4 months after carbon ion radiotherapy. 4.Patients who refuse to participate in this study.

Design outcomes

Primary

Measure	Time frame
Assessment of diagnostic abilities of GSA SPECT or MRI in terms of prediction of residual liver reserve capacity before and 3, 12 months after carbon ion radiotherapy	—

Secondary

Measure	Time frame
Correlation among overall survival rate, treatment completion rate in intent to treat group, liver function indices such as Child-Pugh classification, and other clinical data	—

Countries

Japan

Contacts

Public ContactKana Yamazaki

National Institute of Radiological Sciences (NIRS), QST Dept. of Molecular Imaging and Theranostics

yamazaki.kana@qst.go.jp043-206-4076

Outcome results